Reader 06/09/2020 (Tue) 01:16:34 Id: d42184 No.16010 del
>>16008
-
>>15854
>a nicotinic treatment that might possibly antagonize the blocking action of SARS-CoV-2 on the AChR through a
>possible modulation of the ACE2 – nAChR interaction, would act earlier than anti-cytokine therapies
Translation: A treatment of a drug that controls the effects produced by nicotine might make the blocking action of Covid-19 hostile to a brain-transmitting binding protein through a possible controlled change of the biochemical catalyst that regulates blood pressure reaction to receptors in your central and peripheral nervous system which respond to drugs. Which may work before anti-inflammation drugs.